Research Use Only · User Discretion Advised

Cagrilintide

$95.00

Cagrilintide is an amylin receptor agonist investigated for metabolic regulation and appetite signaling. This compound activates amylin pathways contributing to satiety signaling and glucose homeostasis, distinct from GLP-1 mechanisms.

Research demonstrates effects on food intake suppression and metabolic parameters in preclinical models and early clinical trials. The peptide is frequently studied in combination with GLP-1 receptor agonists, showing complementary effects.

Biohackers interested in multi-pathway metabolic optimization value cagrilintide for its novel amylin-targeting mechanism, representing a different approach compared to GLP-1-focused compounds.